Projected Earnings Date: 2025-08-07    (Delayed quote data   2025-06-27)
Last
 131.82
Change
 ⇑ +1.14   (+0.87%)
Volume
  993,495
Open
 131.06
High
 132.24
Low
 129.32
8EMA (Daily)
 130.97
40EMA (Daily)
 133.93
50EMA (Daily)
 135.10
STO (Daily)
 42.584
MACD Hist (Daily)
 0.440
8EMA (Weekly)
 133.428
40EMA (Weekly)
 143.30
50EMA (Weekly)
 143.32
STO (Weekly)
 20.960
MACD Hist (Weekly)
 -2.024
ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU?s acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com